Source stringclasses 1
value | Date int64 2.03k 2.03k | Text stringlengths 200 965k | Token_count int64 40 185k |
|---|---|---|---|
SEC | 2,025 | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As part of Apple Inc.’s (“Apple’s”) previously announced Chief Financial Officer transition plan, Apple’s Board of Directors appointed Kevan Parekh, 53, as Apple... | 522 |
SEC | 2,025 | Item 7.01 Regulation FD Disclosure
On December 2, 2024, U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) released new interim final rules adding new companies to the U.S. Entity List and further regulating the export of certain semiconductor capital equipment products and services to China-based ... | 139 |
SEC | 2,025 | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 30, 2024, the Board of Directors (the “Board”) of ADMA Biologics, Inc. (the “Company”) appointed Eduardo Rene Salas to serve on the Board as a Class I... | 501 |
SEC | 2,025 | Item 2.06 Material Impairments
On January 9, 2025, AbbVie determined that it will record an impairment charge related to the emraclidine intangible asset acquired as part of the acquisition of Cerevel Therapeutics Holdings, Inc.
On November 11, 2024, AbbVie announced that its two Phase 2 EMPOWER trials investigatin... | 244 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
On January 8, 2025, Albertsons Companies, Inc. issued a press release announcing its financial results for the 12 and 40 weeks ended November 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report and incorporated herein by re... | 222 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition
Reported GAAP earnings and adjusted non-GAAP earnings for the fourth quarter of 2024 are expected to include acquired IPR&D and milestones expense of $1.6 billion on a pre-tax basis, representing an unfavorable impact of $0.88 to both GAAP diluted earnings pe... | 813 |
SEC | 2,025 | ITEM 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Certificate of Incorporation Amendment
In connection with the previously announced name change to Acadian Asset Management Inc. (the “Company”) from BrightSphere Investment Group Inc., on December 31, 2024, the Company filed with th... | 447 |
SEC | 2,025 | Item 7.01. Regulation FD Disclosure.
On January 6, 2025, Agree Realty Corporation (the “Company”) issued a press release announcing the Company’s investment activity for 2024, investment guidance for 2025, and updates on its portfolio as well as its fourth quarter capital markets activity.
A copy of the press ... | 728 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
Members of the senior management team of Acadia Healthcare Company, Inc. (the “Company”) are scheduled to meet with investors at the J.P. Morgan Healthcare Conference during the week of January 13, 2025. In conjunction with these meetings, the Company today ann... | 117 |
SEC | 2,025 | Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS AND FACTORS THAT IMPACT OUR OPERATING RESULTS AND TRENDS
This Form 10-Q contains "forward-looking statements" within the meaning of the federal securities laws. The "forward-looking statements" ... | 10,902 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition
On January 13, 2025, ADMA Biologics, Inc. (the “Company”) issued a press release announcing the Company’s preliminary unaudited full year 2024 revenue and providing a business update.*
Item 9.01 Exhibits.
(d) Exhibits
Exhibit No. Description 99.1
ADMA Biolog... | 214 |
SEC | 2,025 | Item 7.01 Regulation FD.
ADMA Biologics, Inc., a Delaware corporation (the “Company”) hereby furnishes the Corporate Presentation the Company expects to present, in whole or in part, and possibly with modifications, from time to time in connection with presentations to potential investors, strategic partners, industry... | 343 |
SEC | 2,025 | ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On January 6, 2025, Ms. Priya R. Aiyar, Executive Vice President and Chief Legal Officer of American Airlines Group Inc. (the “Company”), notified the Company t... | 332 |
SEC | 2,025 | Item 1.01 Entry Into a Material Definitive Agreement.
On January 14, 2025, Adobe Inc. (“Adobe”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, BofA Securities, Inc., SG Americas Securities, LLC, U.S. Bancorp Investments, Inc. and Wells Fargo Securities, LLC, as ... | 1,521 |
SEC | 2,025 | Item 8.01. Other Events.
On January 14, 2025, New York Mortgage Trust, Inc., a Maryland corporation (the “Company”), completed the issuance and sale of $82.5 million aggregate principal amount of its 9.125% Senior Notes due 2030 (the “Notes”), which includes $7.5 million aggregate principal amount of the Notes issued... | 1,666 |
SEC | 2,025 | Item 2.02. Results of Operations and Financial Condition.
On January 14, 2025, we issued a press release entitled “ACM Research Updates 2024 Revenue Outlook and Provides Initial Outlook for 2025 Revenue.” The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.... | 235 |
SEC | 2,025 | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
James Champy Retirement
On January 9, 2025, James Champy informed the Board of Directors (the “Board”) of Analog Devices, Inc. (the “Company”) that he had dec... | 955 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition
On January 22, 2025, Abbott Laboratories announced its results of operations for the fourth quarter and full year 2024.
Furnished as Exhibit 99.1, and incorporated herein by reference, is the news release issued by Abbott announcing those results. In that news... | 386 |
SEC | 2,025 | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Board Committee Appointment
On December 18, 2024, Autodesk, Inc. (“Autodesk” or the “Company”) filed a Current Report on Form 8-K disclosing, among other thin... | 1,210 |
SEC | 2,025 | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Appointment of Thomas Gartland to the Board of Directors
On January 20, 2025 the Board of Directors (the “Board”) of ADT Inc. (the “Company”) voted to a... | 706 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
On January 28, 2025, Adient plc (the “Company”) issued a news release announcing its financial results for the first quarter ended December 31, 2024. The news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by ... | 227 |
SEC | 2,025 | Item 2.02. Results of Operations and Financial Condition.
On January 29, 2025, the Registrant issued a press release announcing that the Registrant's financial results for the second quarter ended December 31, 2024 were available through an earnings release available on the Registrant's website. A copy of the Registr... | 143 |
SEC | 2,025 | Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This section and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve ris... | 8,958 |
SEC | 2,025 | ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On January 23, 2025, American Airlines Group Inc. (the Company) issued a press release reporting financial results for the three and twelve months ended December 31, 2024. The press release is furnished as Exhibit 99.1 to this report.
ITEM 7.01. REGULATION FD... | 431 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
On January 22, 2025, Alcoa Corporation issued a press release announcing its fourth quarter and full year 2024 financial results. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 2.02.
The infor... | 303 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
Asbury Automotive Group, Inc. (the “ Company ”) issued an earnings release on January 30, 2025, announcing its financial results for the three months and year ended December 31, 2024. A copy of the earnings release is furnished as Exhibit 99.1 to this Current R... | 257 |
SEC | 2,025 | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 29, 2025, Archer-Daniels-Midland Company (the “Company”) announced that the Board of Directors of the Company has appointed Carrie Nichol to serve as... | 987 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
On January 30, 2025, Apple Inc. (“Apple”) issued a press release regarding Apple’s financial results for its first fiscal quarter ended December 28, 2024. A copy of Apple’s press release is attached hereto as Exhibit 99.1.
The information contained in this Cu... | 212 |
SEC | 2,025 | Item 2.02 Results of Operations and Financial Condition.
On February 3, 2025, AECOM issued a press release announcing its financial results for the quarter ended December 31, 2024. A copy of the press release is attached to this report as Exhibit 99.1. Exhibit 99.1 attached hereto shall not be deemed “filed” for p... | 253 |
SEC | 2,025 | Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Item and other sections of this Quarterly Report on Form 10-Q (“Form 10-Q”) contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertai... | 5,228 |
SEC | 2,025 | ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On January 30, 2025, Chonda J. Nwamu, Executive Vice President, General Counsel and Secretary of Ameren Corporation (the “Company”) informed the Company o... | 94 |
End of preview. Expand in Data Studio
No dataset card yet
- Downloads last month
- 6